Related Experiment Video
Updated: Sep 19, 2025

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Barriers and opportunities in donation after circulatory death heart transplantation
Katherine G Phillips1, Darren Stewart2, Brian Wayda3
1Department of Cardiothoracic Surgery, NYU Langone Health, New York, NY.
Insights
Many donation after circulatory death (DCD) hearts are not used, despite being viable for transplantation. Addressing concerns about donor progression and geographic variability could significantly increase heart utilization.
Area of Science:
- Transplantation Medicine
- Cardiovascular Surgery
- Organ Donation Research
Background:
- Heart utilization from donation after circulatory death (DCD) donors shows significant national variability, leading to missed transplantation opportunities.
- Understanding the frequency of non-utilized, yet viable, DCD hearts is crucial for optimizing organ allocation.
Purpose of the Study:
- To quantify the incidence of clinically viable, non-utilized DCD hearts.
- To identify the primary barriers to DCD heart utilization in the United States.
Main Methods:
- Retrospective analysis of the Scientific Registry of Transplant Recipients (SRTR) data for donors aged ≤55 years.
- Evaluation of donor characteristics (age, warm ischemic time, ejection fraction) and reasons for non-recovery or offer refusal.
- Application of the SRTR heart yield model to identify non-utilized DCD hearts comparable to transplanted cases.
Main Results:
- In 2023, only 15.5% of DCD hearts from donors ≤55 years old were utilized, with significant geographic variation observed.
- The SRTR heart yield model identified 701-1,243 non-utilized DCD hearts with characteristics suitable for transplantation.
- Concerns regarding delayed progression to circulatory arrest after life support withdrawal were a primary reason for non-utilization.
Conclusions:
- A substantial number of DCD hearts with favorable characteristics remain unused, despite increased acceptance of DCD heart transplantation.
- Addressing donor viability prediction and geographic disparities could potentially double DCD heart utilization.
- Improving DCD heart utilization could increase annual heart transplant volume by 700-1,200 cases (15%-27%).
Background:
Heart utilization from donation after circulatory death (DCD) donors remains highly variable across the United States, potentially resulting in missed transplantation opportunities. This study aimed to quantify the frequency of clinically viable, non-utilized DCD hearts and identify usage barriers.
Methods:
We conducted a retrospective, national registry analysis of donors ≤55 years old who donated ≥1 organ, focusing primarily on DCDs. Donor characteristics, particularly age, warm ischemic time (WIT), and ejection fraction (EF), as well as reasons for non-recovery and offer refusal, were analyzed. Scientific Registry of Transplant Recipients (SRTRs) heart yield model was employed to identify non-utilized DCD hearts clinically comparable to transplanted DCD hearts.
Results:
In 2023, 613 DCD hearts were transplanted, accounting for 13.5% of all heart transplants. Only 15.5% of DCD hearts from donors ≤55 years old were utilized. Marked variation in risk-adjusted DCD heart yield was observed between states, Organ Procurement Organizations (OPOs), and Regions. Donors of transplanted DCD hearts had a median age of 32, WIT 24 mins, and EF 63%. The yield model identified between 701 and 1,243 non-utilized DCD hearts with characteristics comparable to transplanted cases. Concerns about delayed progression to circulatory arrest after life support withdrawal was a key reason for non-utilization.
Conclusions:
Despite wider acceptance of DCD heart transplantation, an increasing proportion of DCD hearts remain unused despite favorable characteristics. Concerns related to delayed progression to circulatory arrest are a significant barrier to heart utilization. Addressing geographic variability and improving predictive models for donor viability could double DCD heart utilization and expand heart transplantation volume by approximately 700-1,200 (15%-27%) annually.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

